However, neither pharmacological nor genetic ablation of TGFβ signaling can derail the progression of the tumor, due to the suppressive effects of the cytokine on cancer cells (Bardeesy et al, 2006; Ijichi et al, 2006; Hezel et al, 2012). Here, TGFB1 is linked to cancer.